Key result
Document provides the International Journal of Angiology editorial board list with no clinical data.
Why the study?
Heart failure causes high global morbidity and mortality, and the appropriate utilization and selection of device therapies in acute and chronic heart failure remains an ongoing area of research.
This review provides an overview of the available literature, landmark trials, and guidelines for device therapy in acute and chronic heart failure.
No clinical data here; leaves open optimal device selection in heart failure.
Heart failure is a leading cause of morbidity and mortality worldwide. Patients with acute heart failure, cardiogenic shock, and end-stage chronic heart failure may benefit from a variety of device therapies. These devices may serve as a rescue, a bridge to recovery, a bridge to further therapy, or heart replacement therapy. The appropriate utilization of these devices is an ongoing area of research. In this review, we provide an overview of the available literature for device therapy in both the acute and chronic heart failure settings. We will present landmark trials, guidelines, and ongoing areas of research. Our goal is to aid in the appropriate selection of both devices and patients who will benefit.
No takes yet. Share an insight, caveat, or question.
Gorton et al. (2026) studied Heart Failure. Device Therapy was evaluated. This document provides a list of editorial board members for the International Journal of Angiology and does not contain clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: